DOSTINEX

This brand name is authorized in Austria, Australia, Brazil, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Malta, Mexico, Nigeria, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug DOSTINEX contains one active pharmaceutical ingredient (API):

1 Cabergoline UNII LL60K9J05T - CABERGOLINE

Cabergoline is a dopaminergic ergoline derivative endowed with a potent and long-lasting PRL-lowering activity. Read about Cabergoline

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DOSTINEX Tablets	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G02CB03	Cabergoline	G Genito urinary system and sex hormones → G02 Other gynecologicals → G02C Other gynecologicals → G02CB Prolactine inhibitors
Discover more medicines within G02CB03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 8114C, 8115D
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 522718030076017, 522718030076117
Country: CA	Health Products and Food Branch	Identifier(s): 02242471
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00890376, 01662387, 01662393, 06896782, 06896807, 07314569, 07314575, 09278369, 09278375
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 30180-04-12
Country: EE	Ravimiamet	Identifier(s): 1121162, 1733509
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 60867
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 117044
Country: FR	Base de données publique des médicaments	Identifier(s): 69671845
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 138678, 161600, 20889, 376310
Country: HK	Department of Health Drug Office	Identifier(s): 41290
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-951850722
Country: IE	Health Products Regulatory Authority	Identifier(s): 22406, 31854
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4064, 4363
Country: IT	Agenzia del Farmaco	Identifier(s): 028988018, 028988032, 045770017
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1008683, 1008684, 1008685
Country: MT	Medicines Authority	Identifier(s): MA505/01401
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 373M99
Country: NG	Registered Drug Product Database	Identifier(s): B4-5542
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 37206
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 6883
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100094067, 100225061, 100260241, 100260590, 100264753, 100280321, 100341413, 100348190, 100358030, 100362792, 100365543, 100370930, 100385959, 100386769, 100390854, 100401747, 100412308, 100419486, 100423430, 100456136, 100464552, 100468535
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65037001, W65037002, W65037003, W65037004
Country: SG	Health Sciences Authority	Identifier(s): 09545P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 3963051, 7963041
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8681308014436, 8681308014443
Country: ZA	Health Products Regulatory Authority	Identifier(s): 28/21.12/0244